Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EPIPHANY: Pharmacogenomics in Asthma
NCT06385236Phase 4Recruiting
- Sponsor
- University of California, San Diego
- Start
- Feb 2024
- Primary completion
- Jun 2027
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of dupilumab, benralizumab in asthma, sponsored by University of California, San Diego. Started Feb 2024; status: recruiting.
02
Drugs
dupilumabbenralizumab
03
Conditions
asthma
Beyond the preview
Go deeper on NCT06385236.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06385236.